Abstract
Homogeneous assays for determining the concentration of small molecules in biological fluids are of importance for monitoring blood levels of critical drugs in patients. We have developed a strand displacement competition assay for the drugs dabigatran, methotrexate, and linezolid, which allows detection and determination of the concentration of the drugs in plasma; however, a surprising kinetic behavior of the assay was observed with an initial rapid change in apparent FRET values. We found that protein-induced fluorescent enhancement or quenching (PIFE/Q) caused the initial change in fluorescence within the first minute after addition of protein, which could be exploited to construct assays for concentration determination within minutes in the low nanomolar range in plasma. A kinetic model for the assay was established, and when taking the new finding into account, the in silico simulations were in good agreement with the experimentally observed results. Utilizing these findings, a simpler assay was constructed for detection of dabigatran, which allowed for detection within minutes without any time dependencies.
| Original language | English |
|---|---|
| Journal | ACS Sensors |
| Volume | 7 |
| Issue | 3 |
| Pages (from-to) | 856-865 |
| Number of pages | 10 |
| ISSN | 2379-3694 |
| DOIs | |
| Publication status | Published - Mar 2022 |
Keywords
- DNA biosensor
- homogeneous assay
- immunoassay
- PIFE
- PIFQ
- point of care
- quantification
- small-molecule detection
- ANTIBODIES
- PERFORMANCE
- QUANTIFICATION
- DABIGATRAN
- CHROMATOGRAPHY-MASS SPECTROMETRY
- POINT
- PROTEINS
- DNA/metabolism
- Humans
- Dabigatran
- Fluorescence Resonance Energy Transfer/methods
- Proteins